AMENDED AND RESTATED CHANGE IN CONTROL AND SEVERANCE AGREEMENTChange in Control and Severance Agreement • January 17th, 2019 • Loxo Oncology, Inc. • Pharmaceutical preparations • Connecticut
Contract Type FiledJanuary 17th, 2019 Company Industry JurisdictionThis Amended and Restated Change in Control and Severance Agreement (this “Agreement”) is entered into by and between Jennifer Burstein (the “Executive”) and Loxo Oncology, Inc., a Delaware corporation (the “Company”), on June 1, 2018 (the “Effective Date”).
AMENDED AND RESTATED CHANGE IN CONTROL AND SEVERANCE AGREEMENTChange in Control and Severance Agreement • May 8th, 2018 • Loxo Oncology, Inc. • Pharmaceutical preparations • Connecticut
Contract Type FiledMay 8th, 2018 Company Industry JurisdictionThis Amended and Restated Change in Control and Severance Agreement (this “Agreement”) is entered into by and between (the “Executive”) and Loxo Oncology, Inc., a Delaware corporation (the “Company”), on May , 2018 (the “Effective Date”).
CHANGE IN CONTROL AND SEVERANCE AGREEMENTChange in Control and Severance Agreement • March 7th, 2017 • Loxo Oncology, Inc. • Pharmaceutical preparations • Connecticut
Contract Type FiledMarch 7th, 2017 Company Industry JurisdictionThis Change in Control and Severance Agreement (this “Agreement”) is entered into by and between [·] (the “Executive”) and Loxo Oncology, Inc., a Delaware corporation (the “Company”), on March 6, 2017 (the “Effective Date”).